BioSpace News Archive

Funding Secured and Senior Management Team Activated by CEO to Ensure Advancement of all Operational Activities and Completion of Corporate Clinical Milestones

AlzeCure Pharma AB announced that it has received acceptance of a late breaking abstract presentation at the AAT- AD/PD conference, which this year will be kept completely digital on 2-5 April 2020 as a result of the corona virus.

New reference material aims to facilitate and expedite global efforts to detect the novel coronavirus

Mallinckrodt plc confirmed that its subsidiary, Mallinckrodt ARD LLC, received a decision from the U.S. District Court for the District of Columbia in its suit against U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services regarding the company’s calculation of Medicaid drug rebates for Acthar® Gel.

New Research Report by Safe Kids Worldwide Reveals Surprising Ways Kids are Getting into Medicine And What Parents Can Do to Protect Them

Recognition reinforces baricitinib’s potential to be the first FDA-approved medicine for individuals living with alopecia areata

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), announced today that it has agreed to conduct a feasibility study with Kirin Holdings Company, Limited (Kirin) to evaluate the production of a novel complex protein utilizing ProCellEx

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the appointment of Kelvin Neu, M.D., to its Board of Directors.

Canadian Blood Services is concerned by a recent spike in appointment cancellations in several cities related to the COVID-19 pandemic.

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update.